Newsroom

If you want to be in the know about what’s going on at our organization, you’ve come to the right place.

Be sure to check back regularly to get our latest news updates.

The Endocrine Society and the American Society for Bone Mineral Research (ASBMR) have released a statement on the Natpara recall, which includes guidance for physicians on discontinuation of Natpara.

Takeda Update from Sept 17 Meeting

A message from Takeda regarding the US recall of Natpara

This list of questions is intended to help patients work with their doctors to develop a plan for discontinuation of Natpara. It was compiled by The Hypoparathyroidism Association with oversight from our medical advisers. It is not intended as medical advice.

Letter of support from the Association Board for Natapara patients affected by the recent recall.

A note from The HypoPARAthyroidism Association regarding the Natpara recall

Click the header to download Takeda's health care provider letter regarding Natpara Recall

Click the header to download Takeda's patient letter regarding Natpara Recall

Our Supporters